Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither?

Autor: Jäderling F; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. fredrik.jaderling@ki.se.; Department of Radiology, Capio S:T Görans Hospital, Stockholm, Sweden. fredrik.jaderling@ki.se., Bergman M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, S-171 77, Sweden.; Department of Surgery, Capio S:T Görans Hospital, Stockholm, Sweden., Engel JC; Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Mortezavi A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, S-171 77, Sweden.; Department of Urology, University Hospital Zurich, Zurich, Switzerland.; Department of Urology, Karolinska University Hospital Solna, Stockholm, Sweden., Picker W; Department of Radiology, Aleris Cancer Center, Oslo, Norway., Haug ES; Section of Urology, Vestfold Hospital Trust, Tønsberg, Norway., Eklund M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, S-171 77, Sweden., Nordström T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, S-171 77, Sweden.; Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: BMC urology [BMC Urol] 2024 Aug 07; Vol. 24 (1), pp. 168. Date of Electronic Publication: 2024 Aug 07.

Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).

Autor: Löffeler S; Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway., Bertilsson H; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Urology, St. Olav's University Hospital, Trondheim, Norway., Müller C; Department of Oncology, Sørlandet Hospital Trust, Kristiansand, Norway., Aas K; Department of Urology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Department of Clinical Medicine, The Arctic University of Norway (UIT), Tromsø, Norway., Aksnessæther B; Department of Oncology, Møre og Romsdal Hospital Trust, Ålesund, Norway., Pesonen M; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Thon K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Tandstad T; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Oncology, The Cancer Clinic, St Olav's University Hospital, Trondheim, Norway., Murtola T; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Urology, Tampere University Hospital, Tampere, Finland., Poulsen MH; Department of Urology, Odense University Hospital, Odense, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Nordstrøm T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Vigmostad MN; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Ottosson F; Department of Urology, Oslo University Hospital, Oslo, Norway., Holmsten K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Capio St. Göran Hospital, Stockholm, Sweden., Christiansen O; Department of Urology, Innlandet Hospital Trust, Hamar, Norway., Slaaen M; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Research Centre for Age-Related Functional Decline and Disease, Innlandet Hospital Trust, Ottestad, Norway., Haug ES; Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway., Storås AH; Department of Oncology, Oslo University Hospital, Oslo, Norway., Asphaug L; Institute of Health and Society, University of Oslo, Oslo, Norway.; Clinical Trials Unit, Oslo University Hospital, Oslo, Norway., Rannikko A; Department of Urology and Research Program in Systems Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Brasso K; Copenhagen Prostate Cancer Center, Department of Urology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: BJU international [BJU Int] 2024 Jun; Vol. 133 (6), pp. 680-689. Date of Electronic Publication: 2024 Mar 12.

The association between pre-diagnostic levels of psychological distress and adverse effects after radical prostatectomy.

Autor: Nilsson R; Department of Urology Telemark Hospital Trust Skien Norway.; Institute of Clinical Medicine, Faculty of Medicine University of Oslo Oslo Norway., Næss-Andresen T; Department of Surgery, Division of Urology Vestre Viken Hospital Trust Drammen Norway., Myklebust TÅ; Department of Registration Cancer Registry Norway Oslo Norway.; Department of Research and Innovation Møre and Romsdal Hospital Trust Ålesund Norway., Bernklev T; Institute of Clinical Medicine, Faculty of Medicine University of Oslo Oslo Norway.; Department of Research and Innovation Vestfold Hospital Trust Tønsberg Norway., Kersten H; Institute of Clinical Medicine, Faculty of Medicine University of Oslo Oslo Norway.; Department of Research Telemark Hospital Trust Skien Norway., Haug ES; Department of Urology Vestfold Hospital Trust Tønsberg Norway.; Institute for Cancer Genomics and Informatics Oslo University Hospital Oslo Norway.

Publikováno v: BJUI compass [BJUI Compass] 2024 Feb 24; Vol. 5 (5), pp. 502-511. Date of Electronic Publication: 2024 Feb 24 (Print Publication: 2024).

Increased magnetic resonance imaging in prostate cancer management-What are the outcomes?

Autor: Hofmann B; Department of Health Sciences, Norwegian University of Science and Technology, Gjovik, Norway.; Centre for Medical Ethics, University of Oslo, Oslo, Norway., Haug ES; Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway.; Institute of Cancer Genomics and Informatics, Oslo University Hospital, Oslo, Norway.; Norwegian Cancer Registry, Oslo, Norway., Andersen ER; Department of Health Sciences, Norwegian University of Science and Technology, Gjovik, Norway., Kjelle E; Department of Health Sciences, Norwegian University of Science and Technology, Gjovik, Norway.

Publikováno v: Journal of evaluation in clinical practice [J Eval Clin Pract] 2023 Sep; Vol. 29 (6), pp. 893-902. Date of Electronic Publication: 2022 Nov 14.

Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging-detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score.

Autor: Peters M; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: m.peters-10@umcutrecht.nl., Eldred-Evans D; Department of Imperial Prostate, Imperial College London, London, UK., Kurver P; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands., Falagario UG; Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy., Connor MJ; Department of Imperial Prostate, Imperial College London, London, UK., Shah TT; Department of Imperial Prostate, Imperial College London, London, UK., Verhoeff JJC; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands., Taimen P; University of Turku and Department of Pathology, Turku University Hospital, Turku, Finland., Aronen HJ; Department of Radiology, University of Turku, Turku, Finland., Knaapila J; Department of Urology, University of Turku and Turku University hospital, Turku, Finland., Montoya Perez I; Department of Computing, University of Turku, Turku, Finland., Ettala O; Department of Urology, University of Turku and Turku University hospital, Turku, Finland., Stabile A; Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Gandaglia G; Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Fossati N; Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Martini A; Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Cucchiara V; Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Briganti A; Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., Lantz A; Department of Urology, Karolinska University Hospital, Solna, Sweden., Picker W; Department of Radiology, Aleris Cancer Center, Oslo, Norway., Haug ES; Section of Urology, Vestfold Hospital Trust, Tønsberg, Norway., Nordström T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Tanaka MB; Department of Imperial Prostate, Imperial College London, London, UK., Reddy D; Department of Imperial Prostate, Imperial College London, London, UK., Bass E; Department of Imperial Prostate, Imperial College London, London, UK., van Rossum PSN; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands., Wong K; Department of Urology, Epsom and St. Helier's University Hospital Trust, Surrey, UK., Tam H; Department of Imperial Prostate, Imperial College London, London, UK., Winkler M; Department of Imperial Prostate, Imperial College London, London, UK., Gordon S; Department of Urology, Epsom and St. Helier's University Hospital Trust, Surrey, UK., Qazi H; Department of Urology, St. George's Hospital NHS Foundation Trust, London, UK., Boström PJ; Department of Urology, University of Turku and Turku University hospital, Turku, Finland., Jambor I; Department of Radiology, University of Turku, Turku, Finland., Ahmed HU; Department of Imperial Prostate, Imperial College London, London, UK.

Publikováno v: European urology [Eur Urol] 2022 Nov; Vol. 82 (5), pp. 559-568. Date of Electronic Publication: 2022 Aug 11.